Document is current

Article History

Received: 22 March 2018

Accepted: 12 September 2018

First Online: 24 October 2018

Ethics approval and consent to participate

: The study protocol, available on request at , was approved by the institutional review boards at all participating sites (University of Florida, Gainesville and Jacksonville, Florida [617-2009]; Northwestern University, Chicago, IL [STU00020824]; Pennington Biomedical Research Center, Baton Rouge, Louisiana, LA [PBRC 29033]; University of Pittsburgh, Pittsburgh, PA [PRO09090386]; Stanford University, Stanford, CA [5136 (Panel:7)]; Tufts University, Boston, MA [9261]; Wake Forest University, Winston-Salem, NC [IRB00011584]; and Yale University, New Haven, CT [0911005926]). Written informed consent was obtained from all participants.

: Not applicable.

: Dr. Fielding reports grants, personal fees. and other from Axcella Health, personal fees from Cytokinetics, grants and personal fees from Biophytis, personal fees from Amazentis, grants and personal fees from Nestle’, grants and personal fees from Astellas, personal fees from Glaxo Smithkline, personal fees from Abbott, and grant from Lonza outside the submitted work. The other authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.